Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 6/20 | 0.59 |
| ▸ | HTR2A | P28223 | 8/20 | 0.45 |
| ▸ | HRH1 | P35367 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30633009 | 1.00 | ANPEP (0.59) | ANPEPHTR2AHRH1CYP1A2HTR2C | |
| SCHEMBL7196336 | 0.92 | CYP1A2 (0.56) | ANPEPHTR2AHRH1CYP1A2HTR2C | |
| SCHEMBL14169990 | 0.84 | ANPEP (0.47) | ANPEPHTR2ACYP1A2ACHE | |
| SCHEMBL11144393 | 0.83 | CYP1A2 (0.58) | ANPEPHTR2AHRH1CYP1A2HTR2C | |
| SCHEMBL9633656 | 0.81 | HTR2A (0.58) | ANPEPHTR2AHRH1HTR2CHDAC4 | |
| SCHEMBL948086 | 0.81 | ACP3 (0.46) | ANPEPHTR2AHRH1HTR2CACHE | |
| SCHEMBL17070963 | 0.81 | ANPEP (0.57) | ANPEPHTR2AHRH1CYP1A2HTR2C | |
| SCHEMBL22879435 | 0.76 | BCHE (0.47) | ANPEPHTR2AHRH1ACHE | |
| SCHEMBL7127466 | 0.76 | ANPEP (0.61) | ANPEPHTR2AHRH1CYP1A2HTR2C | |
| SCHEMBL10343010 | 0.75 | ACHE (0.55) | ANPEPCYP1A2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360486-A1 | Biorefining Method | LICELLA PTY LTD (AU) | 2025-11-27 | — | — | US | disclosed |
| US-12409437-B2 | Biorefining method | LICELLA PTY LTD (AU) | 2025-09-09 | — | — | US | disclosed |
| EP-4522596-A1 | DIHYDROINDENE DERIVATIVES AS MALT1 INHIBITORS | C4X Discovery Limited (GB) | 2025-03-19 | — | — | EP | disclosed |
| US-20240042414-A1 | Biorefining Method | LICELLA PTY LTD (AU) | 2024-02-08 | — | — | US | disclosed |
| US-11826722-B2 | Biorefining method | LICELLA PTY LTD (AU) | 2023-11-28 | — | — | US | disclosed |
| WO-2023218203-A1 | DIHYDROINDENE DERIVATIVES AS MALT1 INHIBITORS | C4X DISCOVERY LIMITED (GB) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023191721-A2 | PRODUCTION OF ENANTIOPURE ALCOHOLS, AMINES AND ACIDS FROM ALKENES BY CASCADE BIOTRANSFORMATION INVOLVING 1,2-METHYL SHIFT | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-10-05 | — | — | WO | disclosed |
| US-20230145297-A1 | METHODS FOR COLLECTING ELECTRON DIFFRACTION PATTERNS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-11 | — | — | US | disclosed |
| CN-116096712-A | Novel compounds | NRG治疗有限公司 | 2023-05-09 | — | — | CN | disclosed |
| US-20220250031-A1 | Biorefining Method | LICELLA PTY LTD (AU) | 2022-08-11 | — | — | US | disclosed |
| EP-1658067-A1 | INDOLAMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY | Astrazeneca AB (SE) | 2006-05-24 | — | — | EP | disclosed |
| EP-1658069-A1 | HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY | Astrazeneca AB (SE) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005013975-A1 | INDOLAMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2005-02-17 | — | — | WO | disclosed |
| WO-2005013981-A1 | HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2005-02-17 | — | — | WO | disclosed |
| EP-1021454-A1 | 2-HETEROATOM SUBSTITUTED CYCLOPENTADIENYL-CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0880534-A1 | HETEROATOM SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYST SYSTEMS AND METHODS FOR PREPARING THEM | BOREALIS A/S (DK) | 1998-12-02 | — | — | EP | disclosed |
| WO-1998006728-A1 | 2-HETEROATOM SUBSTITUTED CYCLOPENTADIENYL-CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |
| WO-1997028170-A1 | HETEROATOM SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYST SYSTEMS AND METHODS FOR PREPARING THEM | BOREALIS A/S (DK) | 1997-08-07 | — | — | WO | disclosed |
| US-4540705-A | Antidepressant imidazolines and related compounds | STERLING DRUG INC. (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0125410-A2 | Imidazolines and related compounds and preparation thereof | STERLING DRUG INC. (US) | 1984-11-21 | — | — | EP | disclosed |